These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18205712)

  • 1. Exploring the mast cell enigma: a personal reflection of what remains to be done.
    Henz BM
    Exp Dermatol; 2008 Feb; 17(2):91-9. PubMed ID: 18205712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and development of mast cells: implications for molecular medicine.
    Födinger M; Mannhalter C
    Mol Med Today; 1997 Mar; 3(3):131-7. PubMed ID: 9095488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of SCF in the dermis is a prognostic factor for the regression of urticaria pigmentosa.
    Onuma H; Matsui C; Morokashi M
    Eur J Dermatol; 1999 Dec; 9(8):629-32. PubMed ID: 10586131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
    Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.
    Valent P; Ghannadan M; Akin C; Krauth MT; Selzer E; Mayerhofer M; Sperr WR; Arock M; Samorapoompichit P; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2004 Aug; 34 Suppl 2():41-52. PubMed ID: 15291805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?
    Georgin-Lavialle S; Le Saché-de Peufeilhoux L; Martin L; Soucie E; Bruneau J; Barete S; Dubreuil P; Bodemer C; Hermine O; Lhermitte L
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):967-71. PubMed ID: 23763569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
    Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
    Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis.
    Sundram UN; Natkunam Y
    J Cutan Pathol; 2007 Apr; 34(4):289-95. PubMed ID: 17381798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT masters mast cells in kids, too.
    Kambe N; Longley BJ; Miyachi Y; Kabashima K
    J Invest Dermatol; 2010 Mar; 130(3):648-50. PubMed ID: 20145643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early growth response factor-1 contributes to interleukin-13 production by mast cells in response to stem cell factor stimulation.
    Li B; Berman J; Wu P; Liu F; Tang JT; Lin TJ
    J Immunotoxicol; 2008 Apr; 5(2):163-71. PubMed ID: 18569387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
    Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
    Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells as effector cells: a co-stimulating question.
    Bachelet I; Levi-Schaffer F
    Trends Immunol; 2007 Aug; 28(8):360-5. PubMed ID: 17625970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis.
    Ma Z; Tovar JP; Kwong KY; Paek D
    Int Arch Allergy Immunol; 2010; 153(4):413-8. PubMed ID: 20559008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell interactions with the nervous system: relationship to mechanisms of disease.
    Dines KC; Powell HC
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):627-40. PubMed ID: 9184654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells.
    Valent P; Baghestanian M; Bankl HC; Sillaber C; Sperr WR; Wojta J; Binder BR; Lechner K
    Thromb Haemost; 2002 May; 87(5):786-90. PubMed ID: 12038777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.